Showing results (11-20 of 123) with videos related to
Sort By:
Pageof 13
The Biochemical Journal|April 1, 1979
Immunochemical analysis of cartilage proteoglycans. Antigenic determinants of substructuresJ Wieslander, D HeinegårdThe Journal of Biological Chemistry|August 28, 1999
Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodiesT Hellmark, H Burkhardt, J WieslanderKidney International|September 1, 1994
Characterization of anti-GBM antibodies involved in Goodpasture's syndromeT Hellmark, C Johansson, J WieslanderThe Journal of Biological Chemistry|July 18, 2000
Molecular properties of the Goodpasture epitopeA Gunnarsson, T Hellmark, J WieslanderClinica Chimica Acta; International Journal of Clinical Chemistry|March 15, 1990
Sialyllacto-N-fucopentaose II (sialylated Le(a)) coupled to humanserum albumin used as standard in immunoassays of tumour associated antigens CA 19-9 and CA-50 in serumP Masson, A Lundblad, J WieslanderClinica Chimica Acta; International Journal of Clinical Chemistry|August 1, 1977
Determination of the Tamm and Horsfall glycoprotein in human urineJ Wieslander, P Bygren, D HeinegårdNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
Antigen restriction and IgG subclasses among anti-GBM autoantibodiesM Segelmark, R Butkowski, J WieslanderClinical and Experimental Rheumatology|November 10, 2000
How and why should we detect ANCA?M Segelmark, K Westman, J WieslanderRenal Physiology|January 1, 1980
Different antibody response in experimental and spontaneous glomerulonephritisJ Wieslander, P Gygren, D HeinegårdClinical Nephrology|March 1, 1990
Abnormally thin glomerular basement membrane and the Goodpasture epitopeE Pettersson, T Törnroth, J WieslanderPageof 13